Buda Juice Raises $20 Million, Plans NYSE Listing Under BUDA
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 1d ago
0mins
Source: renaissancecapital
- Successful Fundraising: Buda Juice raised $20 million by offering 2.7 million shares at $7.50 each, at the low end of the $7.50 to $9.00 range, providing essential funding for future growth despite market challenges.
- Innovative Product Line: The company is pioneering the 'UltraFresh' juice category through its end-to-end cold chain platform, showcasing its innovative capabilities in the fresh citrus beverage market, which is expected to attract more retail customers and enhance market share.
- Expansion Plans: Currently operating from its Dallas facility, Buda Juice plans to establish new facilities in South Carolina by 2026 and in Arizona/Nevada by 2027, indicating strong confidence in future growth and market expansion.
- Listing Plans: The company intends to list on the NYSE American under the ticker BUDA, a move that will not only enhance brand visibility but also provide more opportunities for capital operations and market expansion.
Analyst Views on BUDA
Wall Street analysts forecast BUDA stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for BUDA is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
0 Analyst Rating
0 Buy
0 Hold
0 Sell
Current: 7.500
Low
Averages
High
Current: 7.500
Low
Averages
High
No data
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
